Shalby Share Price

NSE
SHALBY •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Shalby Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
33.53% Fall from 52W High
-20.2
TTM PE Ratio
Below industry Median
45.3
Price to Book Ratio
Below industry Median
2.4
Dividend yield 1yr %
Below industry Median
0.5
TTM PEG Ratio
PEG TTM is negative
-1.5

Shalby Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Shalby Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
267.54 Cr
278.89 Cr
244.23 Cr
216.05 Cr
237.98 Cr

Shalby Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
953.18 Cr
827.44 Cr
711.37 Cr
439.96 Cr
504.22 Cr

Shalby Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
2.36 Cr
14.74 Cr
16.04 Cr
19.06 Cr
27.58 Cr

Shalby Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
83.5 Cr
67.68 Cr
53.97 Cr
42.36 Cr
27.59 Cr

Shalby Ltd shareholding Pattern

Promoter
74.2%
Foreign Institutions
5.4%
Domestic Institutions
0.1%
Public
19.6%
Promoter
74.2%
Foreign Institutions
5.4%
Public
19.6%
Promoter
74.2%
Foreign Institutions
4.9%
Public
20.1%
Promoter
74.1%
Foreign Institutions
4.6%
Public
20.4%
Promoter
74.1%
Foreign Institutions
4.1%
Public
20.9%
Promoter
74.1%
Foreign Institutions
4%
Public
21%

Shalby Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
232.20
10Day EMA
234.80
12Day EMA
235.00
20Day EMA
234.90
26Day EMA
235.20
50Day EMA
240.10
100Day EMA
250.10
200Day EMA
255.90
5Day SMA
233.10
10Day SMA
238.80
20Day SMA
234.80
30Day SMA
229.20
50Day SMA
237.20
100Day SMA
255.70
150Day SMA
262.90
200Day SMA
262.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
39102 Rs
73211 Rs
Week Rs
55700 Rs
97933 Rs
Month Rs
123839 Rs
207016 Rs
Resistance & Support
227.90
Pivot
Resistance
First Resistance
230.80
Second Resistance
235.93
Third Resistance
238.83
Support
First Support
222.77
Second support
219.87
Third Support
214.74
Relative Strength Index
39.45
Money Flow Index
55.48
MACD
-0.22
MACD Signal
0.56
Average True Range
8.01
Average Directional Index
21.50
Rate of Change (21)
4.61
Rate of Change (125)
-18.40

Shalby Ltd Company background

Founded in: 2004
Managing director: Vikram Shah
Shalby Ltd was originally incorporated as a Private Limited Company with the name Shalby Hospital Private Limited on August 30, 2004. Subsequently, the Company was converted to a Public Limited Company and the name was changed to Shalby Hospital Public Limited on May 15, 2006. Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabadheadquartered and one of the leading multispecialty chain of hospitals in India and provides highquality and economical healthcare services. The Hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. Led by Dr. Vikram Shah, an orthopaedic surgeon, the Hospital has grown from a single hospital to a chain of multispecialty hospitals. Apart from a focus on orthopaedics, the hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology. The Hospitals, Krishna Shalby, SG Shalby, Shalby Indore and Shalby Jabalpur are accredited by the NABH. Further, Krishna Shalby and SG Shalby are also accredited by the NABL. The Hospital currently runs a panIndian chain of 11 multispecialty tertiary hospitals and 4 Single specialty Hospitals (SOCE) across 6 states with a total bed capacity of more than 2,000. Shalby has 59 outpatient clinics (OPDs) across 16 states. It also expanded global presence by opening OPDs in Kenya, Nairobi, Ethiopia, Tanzania, and Uganda in the African continent.In 2007, the Company established operations of its first multispecialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad. The company commenced a new hospital Shalby Vapi at Vapi in April 2012 and thereafter it commenced a new hospital Krishna Shalby in Ahmedabad in October 2012. The company commenced a new hospital Shalby Jabalpur at Jabalpur in Madhya Pradesh in March 2015. The company commenced a new hospital Shalby Indore at Indore in August 2015. In 2016, the company executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby. During the year under review, the company executed an OM agreement with Kamesh Hospital to commence operations of Shalby Mohali. In 2017, the company entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries. The Company came up with an Initial Public Offer of 20,354,838 Equity Shares by raising capital from public aggregating to Rs 504. 8 Crores comprising a Fresh Issue of 19,354,838 Equity Shares amounting to Rs 480 Crores and an Offer for Sale of 1,000,000 Equity Shares amounting to Rs 24.8 Crore in December, 2017.With the increase in demand of digital transformation in healthcare sector, Shalby embarked its journey of digital transformation across its all hospitals from 201819. In 2020, the Company launched Video Assisted Thoracic Surgery (VATS) to reduce the incidence of surgical complications. The Liver Transplant Facility became fully operational at Shalby, Ahmedabad and Mohali.The Company incorporated a new wholly owned subsidiary Company under the name and style Mars Medical Devices Limited on April 3, 2020. The Company also incorporated whollyowned subsidiary company under the name and style Shalby Hospitals Mumbai Pvt. Ltd. on December 10, 2020. In May 2021, the Company acquired the assets of Consensus Orthopaedics, a hip and knee implant manufacturing company with its facility at El Dorado Hills, USA. The Company also commenced multispeciality rehabilitation centre at one of its Unit in 2021. The Company launched a stateoftheart Digital Spine Operation Room at SG Shalby Hospital, Ahmedabad in 2022. In September 2021, the Company launched its first Shalby Orthopedics Centre of Excellence (SOCE) in the country at Udaipur. Centralised cloud based Laboratory Information System (LIS) was launched in 2022. The Company further incorporated Shalby Advanced Technologies Inc. (SAT) in the first quarter of Fiscal 2022.In 202223, the Company launched a new product line of Uni Knee System called as Tahoe Unicompartmental Knee System or TUKS.
Read More

Shalby Ltd FAQs

Shalby Ltd shares are currently priced at 225.67 on NSE and 225.55 on BSE as of 12/19/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Shalby Ltd [SHALBY] share was -24.75. The Shalby Ltd [SHALBY] share hit a 1-year low of Rs. 204.05 and a 1-year high of Rs. 339.5.

The market cap of Shalby Ltd is Rs. 2437.46 Cr. as of 12/19/2024 12:00:00 AM.

The PE ratios of Shalby Ltd is 25.63 as of 12/19/2024 12:00:00 AM.

The PB ratios of Shalby Ltd is 2.21 as of 12/19/2024 12:00:00 AM

You can easily buy Shalby Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -